Showing results (1691-1700 of 3,339) with videos related to
Sort By:
Pageof 334
Metabolic Brain Disease|March 6, 2018
Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizuresParisa Zareie, Mehdi Sadegh, Mohammad Reza Palizvan, et al.Metabolic Brain Disease|December 13, 2017
Neuroanatomical and molecular correlates of cognitive and behavioural outcomes in hypogonadal malesO B Akinola, M O GabrielMetabolic Brain Disease|February 11, 2018
Favourable outcome in a child with symptomatic diagnosis of Glutaric aciduria type 1 despite vertical HIV infection and minor head traumaAngeline Thomas, Els F M Dobbels, Priscilla E Springer, et al.Metabolic Brain Disease|October 4, 2017
Correction to: Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behavioursO J Onaolapo, T B Paul, A Y OnaolapoMetabolic Brain Disease|November 5, 2017
The anxiolytic-like effects of puerarin are associated with the changes of monoaminergic neurotransmitters and biosynthesis of allopregnanolone in the brainZhi-Kun Qiu, De-Sheng Zhong, Jia-Li He, et al.Metabolic Brain Disease|November 5, 2017
Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: a bio-behavioral study in the Flinders Sensitive Line ratInge Oberholzer, Marisa Möller, Brendan Holland, et al.Metabolic Brain Disease|October 29, 2017
Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular modelMohamed Salama, Mahmoud Elhussiny, Alshimaa Magdy, et al.Metabolic Brain Disease|March 9, 2018
Oxidative stress in the brain caused by acute kidney injuryAlexandra Kovalčíková, Marianna Gyurászová, Diana Vavrincová-Yaghi, et al.Metabolic Brain Disease|March 9, 2018
Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in miceDevinder Arora, Jayesh Mudgal, Madhavan Nampoothiri, et al.Metabolic Brain Disease|January 1, 2018
Zeaxanthin improved diabetes-induced anxiety and depression through inhibiting inflammation in hippocampusXiaoyan Zhou, Tian Gan, Gaoxia Fang, et al.Pageof 334